ARTICLE | Company News
BioDuro, BioAtla deal
December 15, 2014 8:00 AM UTC
BioAtla and BioDuro partnered to advance two undisclosed mAbs through preclinical and Phase I trials in China. The companies will out-license the compounds to Chinese biopharmaceutical companies for f...